Metabolic analysis

Metabolomics

Alzheimer’s treatment through metabolic intervention.

The application of this technique allows knowing the state of the organism with respect to a group of metabolic factors directly related to Alzheimer’s disease.

In addition, it allows designing the intervention plan, aimed at balancing all those factors in imbalance to achieve treatment of the disease through metabolic intervention.

82 factors are analyzed , such as the composition of membrane lipids, deficits in energy metabolism and neurotransmission systems, hyperammonemia, hyperlipidemia, oxidative stress, or altered homeostasis of multiple metallic and metalloid elements, among others.

Habit Analysis

Scientific evidence has revealed that certain habits related to stress, sleep, physical activity or fasting are determining factors in preventing the development or reversing the progression of Alzheimer’s disease .

Each of these habits promotes an increase or decrease in the concentration of certain bioactive molecules, which has an impact on the cognitive state and influences the possible subsequent development of Alzheimer’s.

For example, physical strength exercise increases the levels of BDNF, a protein from the neurotrophin family that can have a positive impact on brain functionality through neuronal development and the maintenance of brain and synaptic plasticity.

Fasting and ketogenic feeding, in the same way, affect the production of beta-hydroxybutyrate, which in turn affects the increase in BDNF production.

biochemical analysis

Metabolomic analysis requires taking samples ( which we can do at home ) of blood, urine, hair and feces.

The samples are sent to the reference laboratories in each area and a completely personalized diagnosis and intervention plan is drawn up for each patient.

Genetic analysis

It is very important to know your genetic predisposition for Alzheimer’s, as this allows a method to be put in place to stop the appearance of symptoms.

The main genetic risk factor for the development of Alzheimer’s disease is being a carrier of the APOE-e4 variant. There is another group of variants in other genes that also increase the predisposition to the disease.

performs the collection of saliva samples to perform an analysis and determine the genetic risk of developing Alzheimer’s disease.